EMEA-001440-PIP01-13-M02

Key facts

Invented name
Viekirax
Active substance
Ombitasvir / paritaprevir / ritonavir
Therapeutic area
Infectious diseases
Decision number
P/0179/2018
PIP number
EMEA-001440-PIP01-13-M02
Pharmaceutical form(s)
  • Tablet
  • Age appropriate oral solid form
Condition(s) / indication(s)
Treatment of chronic hepatitis C
Route(s) of administration
Oral use
Contact for public enquiries
AbbVie Ltd

E-mail: paediatricteam@abbvie.com 
Tel. +44 (0)7341101902

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating